(Medicare Policy Initiative) Pilot programs: There have been reports that experiments or pilot programs are being considered to allow Medicare and Medicaid to better cover GLP-1s for obesity (possibly starting 2026/2027) in certain states or under certain conditions
As weight loss drugs continue gaining popularity in medical aesthetics and wellness programs, understanding regulatory changes will help providers make informed decisions prioritizing patient safety and treatment efficacy
Of the total adverse events reported, 37% were gastrointestinal in nature [207 events in 73 (77%) of 95 participants], most frequently nausea [67 events in 53 (56%) participants], vomiting [43 events in 23 (24%) participants], and dyspepsia [32 events in 27 (28%) participants]
For patients with type 2 diabetes, hemoglobin A1c reductions become apparent within 12 to 16 weeks of initiating therapy
It's basically about how we cook our food, non-GMO, no pesticides, eating really organicLiterally, I haven't worked out at all," Clarkson told Extra
Something looks off
